Larvol Delta - LongTerm-Outcomes-and-Predictors-of-Response-to-AntiVEGF-Therapy-for-Diabetic-Macular-Edema-in-Clinical-Practice

Lucentis (ranibizumab) - Roche, Novartis

Lumitin (conbercept) - Chengdu Kanghong Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42329847

Jing Tian; Ling Dong

Jun 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next